Nu Skin appoints James D. Thomas as permanent CFO, replaces interim role

NU SKIN ENTERPRISES, INC.

James D. Thomas named Executive VP and CFO effective July 24, 2023; previously served as Interim CFO since March 2023.
Annual salary set at $450,000 with 75% target bonus; granted $250,000 in RSUs and $250,000 in PRSUs.
Thomas joined Nu Skin in 2010, served as Chief Accounting Officer since 2019, and led M&A and margin improvement projects.
Appointment follows a search including internal and external candidates; no family relationships or related-person transactions reported.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

James D. Thomas

Executive Vice President and Chief Financial Officer

NUS · NU SKIN ENTERPRISES, INC.

Effective: 2023-07-24
Filed: July 27, 2023, 7:59 PM ET

On July 24, 2023, following a search that included internal and external candidates, the Company’s Board of Directors appointed James D. Thomas as Executive Vice President and Chief Financial Officer on a permanent basis.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

James D. Thomas was appointed as Executive Vice President and Chief Financial Officer at NU SKIN ENTERPRISES, INC..

Action: appointed
Role: Executive Vice President and Chief Financial Officer

Exact text from the filing

On July 24, 2023, following a search that included internal and external candidates, the Company’s Board of Directors appointed James D. Thomas as Executive Vice President and Chief Financial Officer on a permanent basis.

View on SEC.gov

NU SKIN ENTERPRISES, INC. filing history →

Source: SEC EDGAR

accession 0001140361-23-036542

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.